Del-Immune V� is made from a unique strain of lactobacillus. Strains of lactobacilli bacteria have been used to produce cheese, yogurt, and other food products throughout history. Other strains of lactobacilli occur naturally in the nose, throat, and our gastrointestinal tract. They serve as an �army� to help protect us from invading pathogens.
In the 1980s, Russian researchers focused on discovering a product to help with immune depression following the Chernobyl accident, as well as to address the anthrax poisoning that occurred due to the destruction of a nearby biological warfare laboratory. The team quickly concluded that vaccines and antibiotics would not be effective. Their research efforts focused on finding a product to activate, enhance, and to quickly boost natural immune system activity. More than 600 different products were examined, including many strains of lactobacillus. Only one product showed dramatic immune system activity: the parent product to Del-Immune.
After confirming the potency of their newly discovered lactobacillus, identified as a lactobacillus bulgaricus, the Russian microbiologists and immunologists successfully �lysed� the cell�destroyed the live cell, leaving small pieces called �cell wall fragments.� Proteins and other components important to the immune system are manufactured within the healthy lactobacillus cells used to make Del-Immune. But these important proteins, complex sugars, and other structures exist on the inside of the cell so they are not visible to the immune system. When the cell walls are fractured, the immune-activating proteins are available to do their job. Click here for a research study.
In the Russian laboratory, the immune-boosting properties of the parent lactobacillus to Del-Immune were proven to be a potent product for immune depression and to provide protection against biowarfare pathogens. The activity is attributed to the fragments containing proteins and other substances that activate switches in the immune system. This switch is called a cytokine, more specifically identified as IFN a. This cytokine acts as a messenger to Interleukin I and VI. These are like �superhighways� into the immune system, and they stimulate essential T cells, B cells, NK cells, and other systems. These are important white cells that protect against infections. Interleukin I protects internal bodily systems that are wet, such as the lungs, throat, nose and kidney. Interleukin VI is anti-inflammatory and helps build bone.
The clinical benefits of the lactobacillus cell-wall fragments were studied in the State Cancer Hospital in Saint Petersburg starting in 1992. In 2000, a Boulder, Colorado pharmacist, John A. Sichel, discovered the product could control his daughter�s hepatitis C infection. Through a contract with the Russian owners, he arranged to manufacture, distribute, and market the product in the U.S. under the name Del-Immune V.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.
Go back to Del-Immune order page.
